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Background: Cardiovascular and kidney diseases are a global public health problem and impose 
a huge economic burden on health care services. Homocysteine, an amino acid, is associated 
with coronary heart disease, while urea is a harmful metabolic substance which can be used 
to reflect kidney function. Monitoring of these two substances is therefore very important. 
This in vitro study aimed to determine whether homocysteine is extractable transdermally and 
noninvasively, and whether homocysteine and urea can be extracted simultaneously by reverse 
iontophoresis.
Methods: A diffusion cell incorporated with porcine skin was used for all experiments with 
the application of a direct current (dc) and four different symmetrical biphasic direct currents 
(SBdc) for 12 minutes via Ag/AgCl electrodes. The dc and the SBdc had a current density of 
0.3 mA/cm2.
Results: The SBdc has four different phase durations of 15 sec, 30 sec, 60 sec, and 180 sec. It was 
found that homocysteine can be transdermally extracted by reverse iontophoresis.   Simultaneous 
extraction of homocysteine and urea by reverse iontophoresis is also possible.
Conclusion: These results suggest that extraction of homocysteine and urea by SBdc are phase 
duration-dependent, and the optimum mode for simultaneous homocysteine and urea extraction 
is the SBdc with the phase duration of 60 sec.
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Introduction
Cardiovascular disease is a challenging global public health problem, causing about 
16.7 million deaths annually worldwide.1 Meanwhile, kidney disease is reportedly 
increasing in developed countries, including the US, Canada, Australia, and Europe.2,3 
Cardiovascular disease and kidney disease impose a substantial economic burden, not 
just on health care services but also on industry and commerce. Taiwan also faces 
these challenges, with heart disease and kidney disease being, respectively, the second 
and eighth leading causes of death in 2007.4 Therefore, there is a need to reduce the 
occurrence and death rate by means of frequent monitoring of patients who are at high 
risk of developing cardiovascular disease or kidney disease. On the other hand, a large 
clinical study has shown that the increased risk of heart disease across the spectrum of 
kidney disease has been recently appreciated by the medical community.5,6 Therefore, 
simultaneous monitoring of cardiovascular disease and kidney disease is essential.
Homocysteine is an amino acid. Highly elevated homocysteine levels were associ-
ated with a more than three-fold increase in the risk of heart attack over a five-year 
period.5 Therefore, the blood homocysteine level is a good index for heart attack International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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monitoring. Conversely, urea in the plasma increases with the 
degree of renal failure and accumulates in kidney disease.6 
Therefore, the clinical diagnosis of chronic kidney disease 
is principally based on the measurement of increased levels 
of urea.
Blood sampling is the current routine clinical method to 
determine blood homocysteine and urea levels. However, 
this method is invasive, painful, aesthetically unpleasant, 
and inconvenient. This provides considerable impetus for the 
development of noninvasive methods for the simultaneous 
monitoring of blood homocysteine and urea levels. So far, no 
research has been reported on investigation of transdermal 
extraction of homocysteine by reverse iontophoresis. Several 
papers have reported on the use of reverse iontophoresis to 
enhance the extraction of urea,7–9 but no papers have been 
found for the simultaneous transdermal extraction of urea 
and homocysteine by this method.
Reverse iontophoresis refers to the passage of a low 
voltage (#10 V) and low level of current (#0.5 mA/cm2) 
through the skin to promote the extraction of both charged 
and neutral molecules.10 The most successful reverse ion-
tophoresis application for patient monitoring to date, as 
mentioned, has been in noninvasive and continuous blood 
glucose detection utilizing the GlucoWatch®.11,12
The aim of this study was to find out whether homo-
cysteine is extractable transdermally and noninvasively, and 
whether homocysteine and urea can be extracted simultane-
ously by reverse iontophoresis.
Materials and methods
reagents and solutions
All reagents used in this study were commercially available 
and used without further purification. Phosphate-buffered 
saline, urea, and homocysteine were purchased from Sigma 
Chemical Company (St Louis, MO). The urea assay kit 
was purchased from BioVision (Mountain View, CA). The 
homocysteine assay kit was purchased from IBL-America 
(Minneapolis, MN). Deionized water, purified by a Millipore 
Milli-Q UFplus System (Bedford, MA) was used to prepare 
all solutions.
equipment
The diffusion cell used for the in vitro studies was the same as 
that previously described (Figure 1).13 A reverse iontophore-
sis device was homemade, with an accuracy of ±0.01 µA for 
delivering current and ±0.01 msec for timing. All colorimetric 
analysis was performed using a Bio-Rad 680 microplate 
reader (Bio-Rad, Hemel Hempstead, UK).
In vitro studies
The diffusion cell was used for all experiments. It consisted 
of two upper electrode chambers and a lower chamber. The 
electrode chambers were separated from the lower chamber 
by porcine ear skin with a thickness of 250 µm, obtained 
by Padgett Dermatome (Integra LifeSciences Corpora-
tion, Plainsboro, NJ). The thickness of the skin used in this 
study was the same as that reported in other researchers’ 
Reverse iontophoresis device
+ –
Electrode
chamber
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skin
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0.1 M PBS (pH 7.0)
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diffusion studies.17,18 All chambers were filled with 0.1 M 
phosphate buffer (pH 7.0), except that the lower chamber 
additionally contained 5 mM urea and 15 µM homocysteine, 
which attempted to simulate the normal physiological levels 
of urea and homocysteine in human blood. Each upper elec-
trode chamber contained 300 µL phosphate buffer (0.1 M, 
pH 7.0) while the lower chamber contained the necessary 
solution of about 25 mL. A Ag/AgCl electrode was positioned 
inside each electrode chamber, and its fabrication procedure 
was the same as previously described.13 The surface area of 
the porcine skin exposed to the electrode in each chamber was 
0.2 cm2 and the electrode chambers were 11 mm apart.
A direct current (dc, cathodal dc abbreviated to dc-cathode 
and anodal dc abbreviated to dc-anode) and four symmetrical 
biphasic direct currents (SBdc) were applied for 12 minutes 
and 36 minutes via the Ag/AgCl electrodes. The dc and the 
SBdc had a current density of 0.3 mA/cm2. The four SBdc 
had four different phase durations of 15 sec (15s PDSBdc), 
30 sec (30s PDSBdc), 60 sec (60s PDSBdc), and 180 sec 
(180s PDSBdc). At the end of each experiment, the entire 
contents of the electrode chambers were removed to deter-
mine the amount of urea and homocysteine extracted.
For the control experiments, all the experimental arrange-
ments and procedures were the same, except no current 
was applied.
Determination of extracted  
urea and homocysteine
The amount of urea (determined by the urea assay kit) and 
homocysteine (determined by the homocysteine assay kit) 
extracted through the porcine skin were quantified by a colo-
rimetric clinical chemistry assay method adapted for use with 
the Bio-Rad 680 microplate reader. To perform the urea and 
homocysteine quantifications, we followed their corresponding 
assay procedures mentioned in the user manuals of their assay 
kits,19,20 except that the amount of sample used was 100 µL 
rather than the recommended amount. An excellent linear 
relationship (r2 . 0.95) between urea concentration and its 
relative absorbance was found, and the relationship between 
homocysteine concentration and its relative absorbance was 
also found to be linearly excellent (r2 . 0.9). This allowed the 
urea and homocysteine concentrations to be calculated simply 
by linear regression.
statistical analysis
One-way analysis of variance was used to determine 
whether there were significant differences between the dc 
and SBdc for urea and homocysteine extraction. Post hoc 
comparisons were made with the least significant difference 
(LSD) test. All statistical analyses were carried out using 
SPSS 10.0 software (SPSS, Chicago, IL), with the level of 
statistical significance set at P , 0.05.
Results and discussion
An in vitro model was used in this study because of its 
simplicity. We were able to create a normal (ie, healthy) 
model, a cardiovascular disease model, and a kidney disease 
model, by just simply adjusting the solution stored inside 
the lower chamber of the diffusion cell. For example, the 
kidney disease model could be created by preparing the lower 
  chamber solution with a high urea concentration, ie, 20 mM 
urea. On the other hand, it is relatively difficult and expen-
sive to create an in vivo model. Hence, an in vitro model 
was used in this study. We simply used the normal model 
(5 mM urea and 15 µM homocysteine) for this investigation 
in order to find out whether homocysteine was extractable, 
as well as whether homocysteine and urea could be extracted 
simultaneously. In a future study, cardiovascular disease and 
kidney disease models will be used.
Skin consists of three layers, ie, the epidermis, dermis, 
and subcutis. The epidermis (about 100 µm in thickness) is 
the topmost layer of the skin, forming a barrier for many 
substances going in and out. The in vitro model used in this 
study also had these three layers. The diffusion cell used 
in this study had a lower chamber, and its function was to 
simulate the dermis and subcutis. For the epidermis, a porcine 
ear skin was used, and its thickness (250 µm) was the same 
as the thickness reported in diffusion studies done by other 
researchers.17,18
There are three mechanisms for reverse iontophoresis, 
ie, diffusion (almost negligible), electromigration, and 
electro-osmosis. The major mechanisms for transport of 
ions and molecules are electromigration of charged species 
to the electrode of opposite polarity, electro-osmosis of 
neutral molecules to the cathode or anode, or a combination 
of these two processes.
Homocysteine, an uncharged molecule with a molecular 
weight of about 135 Da, is a hydrophilic molecule (partition 
coefficient -2.2). Because of its small size and hydrophilic 
properties, homocysteine is expected to be transdermally 
extractable by electro-osmosis. Urea is a negatively charged 
molecule and its molecular weight is about 60.06 Da. As a 
consequence of its small size and negative charge, electromi-
gration is the dominant physical factor for urea extraction.
As expected, reverse iontophoresis facilitated the trans-
dermal extraction of homocysteine and urea (see Figure 2). International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 2A shows that there was a significant difference 
between the dc and the four SBdc on extraction of homo-
cysteine (one-way analysis of variance, P , 0.001). It was 
found that there was a significantly higher homocysteine 
extraction for the dc and the four SBdc than for the control 
sample which utilized diffusion-only extraction (LSD test, 
P , 0.001 in most cases and P , 0.05 in the remaining 
cases). This suggests that the use of physical force, like 
reverse iontophoresis, can promote more homocysteine 
extraction than diffusion alone. Because homocysteine is an 
uncharged molecule, it theoretically should be extracted to 
the electrode chamber of the diffusion cell with the negative 
polarity (ie, the cathode). As shown in Figure 2A, although 
slightly higher homocysteine extraction was observed at the 
cathode than at the anode, the difference was not significant. 
This might be because prolonged dc passage can cause skin 
polarization, which results in the reduction of electro-osmotic 
flow. Homocysteine extractions at the dc-cathode and the 
dc-anode were found to be significantly lower than that 
at the four SBdc (LSD test, P , 0.001 in most cases and 
P , 0.05 in the remaining cases). A possible explanation 
is that the use of dc for reverse iontophoresis causes skin 
polarization. Polarization effects turn the skin into what is 
effectively a charged capacitor, and this reduces the flow of 
current and charged species during reverse iontophoresis. 
However, the use of SBdc has been suggested as a means to 
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Figure 2 The transdermal extraction of A) homocysteine and B) urea (mean ± standard deviation; n $ 3 for each bar) by reverse iontophoresis. The extraction period was 
12 minutes and 36 minutes. The current density of the extraction was 0.3 mA/cm2; 15s, 30s, 60s, and 180s PDsBdc corresponds to the symmetrical biphasic direct current 
with the phase duration of 15 seconds, 30 seconds, 60 seconds, and 180 seconds, respectively. The dc-cathode and dc-anode correspond to a cathode of direct current and 
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overcome skin polarization.14,15 Therefore, SBdc promoted 
more homocysteine extraction than dc. Also, homocysteine 
extraction using 60s PDSBdc was found to be significantly 
higher than that with protocols utilizing 15s PDSBdc (LSD 
test, P , 0.001) and 30s PDSBdc (LSD test, P , 0.05) but 
there was no significant difference when using 180s PDSBdc 
(LSD test, P = 0.838). This result suggests that extraction of 
homocysteine by SBdc is phase duration-dependent. Because 
a plateau was observed at 60s PDSBdc and 180s PDSBdc 
for homocysteine extraction, the optimum mode for homo-
cysteine extraction is therefore the 60s SBdc. Moreover, it 
was found that a longer extraction time resulted in relatively 
more homocysteine extraction. However, a three-fold increase 
in extraction time did not result in a three-fold increase in 
homocysteine extraction (see Figure 2A). More importantly, 
the homocysteine extraction flux (see Figure 3A) and even 
effective homocysteine extraction (see Table 1) decreased 
with increased extraction time. This indicates the presence 
of a homocysteine reservoir in the skin.
On the other hand, as shown in Figure 2B, a significant 
difference was found between dc and the four SBdc for the 
extraction of urea (one-way analysis of variance, P , 0.001). 
Again, the dc and the four SBdc were found to promote more 
urea extraction than diffusion alone (LSD test, P , 0.001 in 
most cases and P , 0.05 in the remaining cases). Because 
urea carries a negative charge, urea should theoretically be 
extracted to the electrode chamber of the diffusion cell with 
the positive polarity. As shown in Figure 2B, our results 
agreed with this theoretical phenomenon that the dc-anode 
facilitates significantly (P , 0.001) more urea extraction 
than the dc-cathode. Urea extraction using the dc-anode was 
found to be significantly higher than that of protocols   utilizing 
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15s PDSBdc and 30s PDSBdc (LSD test, P , 0.001 in all 
cases) but there was no significant difference using 60s 
PDSBdc (LSD test, P = 0.139) and 180s PDSBdc (LSD 
test, P = 0.540). However, as shown in Table 1, it could be 
argued that because the dc and SBdc have different effective 
extraction times (defined as the total number of hours for 
the passage of current at the same polarity during the whole 
experimental time), a standardization technique should be 
employed to investigate the rate of transdermal extraction 
of urea. Therefore, the extraction rate for urea was recalcu-
lated in nmol/hour, where time was set as the actual time of 
the applied current at the electrode chamber collecting the 
molecule. This is based on the assumption that, at any time 
in the cycle, the anode dominates the collection of urea. 
As shown in Table 1, calculating the effective urea extrac-
tion amount in this format shows that urea extraction using 
the dc-anode was significantly lower than when using SBdc 
(LSD test, P , 0.001 in all cases). On the other hand, urea 
extraction using 60s PDSBdc was found to be significantly 
higher than when using 15s PDSBdc and 30s PDSBdc (LSD 
test, P , 0.001 in all cases) but lower than that when using 
180s PDSBdc (LSD test, P , 0.05). This result suggests that 
extraction of urea by SBdc is also phase duration-dependent. 
Although 15s, 30s, 60s, and 180s PDSBdc showed the same 
effective urea extraction time, it was found that a long PDSBdc 
results in higher urea extraction. Because skin has a thickness 
dimension, urea takes some time to pass through the skin. For 
a short PDSBdc, some urea molecules may not have enough 
time to pass through and may stay inside the skin. These urea 
molecules will not move forward into the   collection chamber, 
and may even move backwards to the lower chamber of the 
diffusion cell when the phase of the SBdc is reversed. This 
might explain the phase duration-dependent phenomenon. 
Because urea extraction using 60s PDSBdc was slightly 
lower than that using 180s PDSBdc (LSD test, P = 0.045), 
the optimum mode for urea extraction is 60s SBdc in order 
to achieve simultaneous extraction of urea and homocysteine. 
On the other hand, it was found that a longer extraction time 
caused comparatively more urea extraction, although a three-
fold increase in extraction time could not cause a three-fold 
increase in urea extraction (see Figure 2B). Moreover, the urea 
extraction flux (see Figure 3B) and even the effective urea 
extraction (see Table 1) decreased with increased extraction 
time. This also indicates the presence of a urea reservoir in 
the skin. Conversely, as shown in Figure 3B, the result of dc-
anode urea extraction flux in 36 minutes (about 0.05 µmole/
cm2/hour ≈ 0.01 µmole/hour) was found to be in agreement 
with the findings reported by Wascotte et al in 2007.7 They 
found that the urea extraction flux in 30 minutes was about 
0.015 µmole/hour. However, our finding of PDSBdc urea 
extraction flux in 36 minutes (see Figure 3B) was higher than 
that of Wascotte et al. This means that PDSBdc resulted in a 
higher urea extraction flux as compared with dc alone.
Based on our findings, reverse iontophoresis potentially 
provides a promising technique for simultaneous, noninva-
sive, and transdermal extraction of urea and homocysteine. 
However, it does not mean that this is applicable in humans. 
Therefore, ethic approval has been applied for to do further 
Table  1  effect  of  the  direct  current  and  the  symmetrical  biphasic  direct  currents  on  effective  urea  and  homocysteine 
extraction (n $ 3)
Current 
waveform
Experimental 
time (h)
Effective extraction 
timea (h)
Effective urea  
extractionb (nmol/h)
Effective homocysteine 
extractionc (nmol/h)
Control 0.2 0.2 3.4 ± 0.7 1.8 ± 0.6
dc-cathode 0.2 0.2 8.1 ± 1.2 4.8 ± 0.9
dc-anode 0.2 0.2 24.8 ± 1.5 4.3 ± 1.1
15s PDsBdc 0.2 0.1 33.6 ± 4.2 15.5 ± 2.0
30s PDsBdc 0.2 0.1 36.1 ± 2.3 18.7 ± 2.1
60s PDsBdc 0.2 0.1 46.3 ± 2.1 22.7 ± 2.4
180s PDsBdc 0.2 0.1 50.9 ± 2.1 22.4 ± 1.8
Control 0.6 0.6 2.1 ± 0.6 1.1 ± 0.5
dc-cathode 0.6 0.6 4.1 ± 0.8 2.5 ± 0.6
dc-anode 0.6 0.6 10.0 ± 0.8 1.7 ± 0.5
15s PDsBdc 0.6 0.3 20.9 ± 1.8 9.7 ± 1.5
30s PDsBdc 0.6 0.3 22.8 ± 1.4 11.8 ± 1.0
60s PDsBdc 0.6 0.3 29.6 ± 1.0 14.5 ± 1.6
180s PDsBdc 0.6 0.3 22.1 ± 1.7 15.3 ± 1.8
Notes: aEffective extraction time is defined as the total number of hour for the passage of current at the same polarity during the whole experimental time; beffective urea 
extraction = Number of mole of extracted urea after the whole experiment/effective extraction time; ceffective homocysteine extraction = Number of mole of extracted 
homocysteine after the whole experiment/effective extraction time.International Journal of Nanomedicine
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research. Once the human study is approved, experiments 
will be conducted to test our hypothesis that homocysteine 
is transdermally extractable, and that homocysteine and urea 
can be simultaneously extracted in humans. If our hypothesis 
is correct, a homocysteine-urea Glucowatch may be able to 
be developed in the future. This could help potential users to 
have a screening test inhouse. Of course, a homocysteine-urea 
watch may face the same reproducibility problems as those 
found with the Glucowatch. Therefore, intensive research will 
be necessary to overcome this reproducibility problem.
Conclusion
A novel method for noninvasive transdermal   extraction 
of homocysteine by reverse iontophoresis has been 
  demonstrated. Reverse iontophoresis facilitates   transdermal 
extraction of homocysteine and urea at the same time. The 
optimum mode for simultaneous homocysteine and urea 
extraction appears to be SBdc with a phase duration of 
60 seconds. Once this hypothesist is proven in humans in 
the future, this new method for urea and homocysteine 
monitoring would be beneficial to patients, such as those 
with kidney disease, or obese individuals who are at high 
risk of developing coronary artery disease.
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